MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer

Clinical trial NCT01263145 · COMPLETED

Trial details

NCT number: NCT01263145
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Solid Neoplasm Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2011-01-05
Primary completion: 2012-10-19
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.